BOB体育

Skip to main content
(352) 733-0111

Lactobacillus johnsonii N6.2 in children and adolescents with T1D

  • Status
    Accepting Candidates
  • Age
    8 Years - 18 Years
  • Sexes
    All
  • Healthy Volunteers
    No
I'm interested
Share this study

Objective

While genetics demonstrated a major risk factor for the development of type 1 diabetes (T1D), microbiota dysbiosis has been suggested as an elicitor in immunological tolerance and of beta cell autoimmunity. The probiotic Lactobacillus johnsonii N6.2 may prevent or restore the gut flora and show systemic impacts and adaptive immunity in the T1D population thereby preserving beta cell function.

Details

Full study title Evaluation of the safety, tolerability, and general response to Lactobacillus johnsonii N6.2 in children and adolescents with T1D
Protocol number OCR22462
ClinicalTrials.gov ID NCT03961854
Phase Phase 2

Eligibility

Inclusion Criteria:

  • have confirmed T1D by physician diagnosis

  • have normal values at screening for complete blood count (CBC) and complete metabolic profiles (with the exception of fasting glucose and HbA1c)

  • are able to swallow a capsule

  • are willing to complete weekly online questionnaires

  • are willing to consume a probiotic

  • are willing to provide stool samples throughout the study

  • are willing to provide blood samples throughout the study

  • are willing to take three stimulated C-peptide tests

  • are able to access a computer with Internet throughout the study

Exclusion Criteria:

  • being treated for any diseases or illnesses such as gastrointestinal disease (gastric ulcers, Crohn's disease, ulcerative colitis, etc.)

  • being treated for chronic kidney disease

  • have had or are currently being treated for other immune-compromising diseases or conditions (HIV, AIDS, hepatitis, cancer, leukemia, organ transplant, Lupus, DiGeorge syndrome, selective deficiency of IgA, Bruton's disease etc.)

  • have an underlying structural heart disease

  • currently live with an immunocompromised person

  • are currently taking medications for constipation and/or diarrhea

  • have taken antibiotics within the past 2 weeks prior to randomization

  • are currently taking a probiotic supplement and are unwilling to discontinue it a minimum of 2 weeks prior to the study start

  • are a current smoker

  • are currently pregnant or lactating or a female who plans to become pregnant in the next 6 months

  • have a known allergy to milk or milk protein.

Lead researcher

Participate in a study

Here are some general steps to consider when participating in a research study:

  1. Step
    1

    Contact the research team

    Call or email the research team listed within the specific clinical trial or study to let them know that you're interested. A member of the research team, such as the researcher or study coordinator, will be available to tell you more about the study and to answer any questions or concerns you may have.

    Primary contact

  2. Step
    2

    Get screened to confirm eligibility

    You may be asked to take part in prescreening to make sure you are eligible for a study. The prescreening process ensures it is safe for you to participate. During the prescreening process, you will be asked some questions and you may also be asked to schedule tests or procedures to confirm your eligibility.

  3. Step
    3

    Provide your consent to participate

    If you are eligible and want to join the clinical trial or study, a member of the research team will ask for your consent to participate. To give consent, you will be asked to read and sign a consent form for the study. This consent form explains the study's purpose, procedures, risks, benefits and provides other important information, such as the study team's contact information.

  4. Step
    4

    Participate

    If you decide to participate in a clinical trial or study, the research team will keep you informed of the study requirements and what you will need to do to throughout the study. For some trials or studies, your health care provider may work with the research team to ensure there are no conflicts with other medications or treatments.